Drug "Baralgin": ntuziaka maka ojiji

Nkwadebe "Baralgin» onye mejupụtara nwere n'ọrụ umi - sodium metamizole, emepụta mbadamba ụdị. The ọgwụ bụ nke otu ìgwè nke na-adakarị na pharmacological analgesic-antipyretics.

Pharmacological edinam dabeere na analgesic na antipyretic Njirimara. The agwọ ọrịa "Baralgin" bụ a na-abụghị narcotic ọgwụgwọ gị n'ụlọnga, na pyrazolone emepụta. Ọzọkwa ya nwere a nta mgbochi mkpali mmetụta.

The usoro nke edinam bụ otu ihe ahụ dị ka nke ndị ọzọ analgesic ọgwụ ndị so ná ndị na usoro.

Metamizole ọma etinye obi gị dum site na aru si eriri afọ tract, metabolized na anyụpụ site na akụrụ ya.

Drug "Baralgin". Ntuziaka. na-agba akaebe

The ọgwụ na-kenyere mgbu ọrịamkpokọta nke dị iche iche mmepe, na feverish.

Drug "Baralgin". Ntuziaka. onunu ogwu

The ọgwụ na-kenyere iji belata ahu okpomọkụ nke a ọgwụgwọ bụghị karịa 3 ụbọchị.

The ọgwụ na-kenyere mgbu ọgwụgwọ N'ezie agaghịkwa karịa 5 ụbọchị.

1 mbadamba mejupụtara nke 500 mg metamizol na-atụ aro ka a otu dose maka ndị mmadụ n'okpuru 15 afọ. Dị ka dọkịta ahụ ezi uche na-alụbeghị di dose nwere ike ụba 2 mbadamba. Mbadamba e 2-3 ugboro n'ụbọchị.

The kacha kwa ụbọchị dose ekwesịghị arụnyere n'elu 3000 mg, nke kwekọrọ 6 mbadamba.

Na pụrụ iche ikpe, a ọgwụgwọ ma ọ bụ karịa na kacha dose nwere ike ike ịgbatị n'okpuru nlekọta nke a dibịa.

Drug "Baralgin". Ntuziaka. mmetụta

Na-enwe nsogbu ndị hematopoietic usoro egosipụta site leukopenia, agranulocytosis na thrombocytopenia dịghịzi si malite.

Ụfọdụ na urinary tract daa ọrịa gosipụtara akụrụ, oliguria, anuria, proteinuria, nnọọ adịkarịghị - jed. Mgbe metobolizme ọgwụ "Baralgin" rubazonovoy erekasịchaala etolite acid nke nwere ike n'iku a mmamịrị red.

Nfụkasị Jeremaya bụ urticaria, angioneurotic edema, exudative erythema, Lyell syndrome, bronchospastic syndrome, anaphylactic ujo.

Ndị ọzọ na-anaghị ekwe nke ahụ e gosiri na adakarị ọnwụnwa usen mgbali, oge ufodu obi n'afọ iri na ụma.

Drug "Baralgin". Ntuziaka. contraindications

Ọ gaghị ekwe omume nye iwu a ọgwụ na ndị na-esonụ mgbe:

• na hepatic porphyria;
• congenital erughi nke glucose-6-phosphate dehydrogenase;
• bronchial ụkwara ume ọkụ;
• na m na-III-nke na-atọ trimester nke dị ime;
• na ọrịa ndị metụtara bronchospasm;
• aṅụ, rhinitis, edema aa na ọrịa na-anata ụfọdụ ọgwụ;
• nnukwu umeji akụrụ ọrịa,
• na agranulocytosis, na-efe efe tsitoplasticheskoy neutropenia;
• maka ụmụaka n'okpuru afọ 15;
• hypersensitivity ka metamizol.

The agwọ ọrịa "Baralgin" isi ọwụwa kwesịrị iwere nke ọma n'okpuru belata nsogbu, ruo ogologo oge ara esogbu ọbara, n'ihi na ihe atụ, n'oge myocardial infarction, multiple trauma ma ọ bụ na-akpata. Akọ ebe metamizol achọ ọrịa na-ata ahụhụ site na gbasara akụrụ ọrịa ndị dị ka pyelonephritis, glomerulonephritis.

Drug "Baralgin" n'oge ime na lactation

Na 4th, 5th, 6 ọnwa nke afọ ime, nwanyi enweghị ike contraindications na ojiji nke ọgwụ ọjọọ, ma ọgwụgwọ a ga-rụrụ n'okpuru n'esepụghị aka nlekọta nke a dọkịta, iji gwọọ ọrịa. Ndị fọdụrụ ọnwa nke afọ ime na nkà mmụta ọgwụ "Baralgin" bụghị kenyere.

Metobolity ọgwụ na-aga n'ime mmiri ara. Na lactating ara na-atụ aro ka ha kwụsị n'ụbọchị nke abụọ ozugbo ọgwụ ochichi.

Special ntụziaka metụtara ndị ọgwụgwọ nke ọrịa ndị na-kenyere cytotoxic ọgwụ ọjọọ na metamizole sodium. Ọ dị mkpa ka ha nye ha a zuru ike na-elekọta.

Ọ bụ adịghị anakwere na-ekenye "Baralgin" ọgwụ ọjọọ na-emeso nnukwu ihe mgbu na afo, mgbe ihe na-akpata na-adịghị ike.